Full Press Release Details
Background:
The background highlights the challenges faced by veterans with TRD, suicide risk, and PTSD symptoms, emphasizing the need for effective and durable treatment options.
Objective:
The primary objective is to assess the durability of deep transcranial magnetic stimulation in improving symptoms of TRD, reducing suicide risk, and alleviating PTSD symptoms among veterans.
Methods:
Data were retrospectively analyzed from 99 adult participants (Veterans). Veterans underwent 30 sessions of dTMS treatment including a tapering phase consisting of 6 sessions. The PHQ-9, PCL- 5, and BSS were administered to Veterans at four time points: pretreatment, post-treatment, three months after treatment, and six months after treatment.
Results:
There were clinically significant reductions in symptoms of depression (43.47%), PTSD (44.14%) and suicidal ideation (54.02%) at the six-month follow-up relative to pretreatment.
Conclusions:
Results provide evidence of the impact and durability of Deep TMS on symptoms of MDD, PTSD, and suicidal ideation among Veterans with treatment-resistant depression.